01 1Dasami Lab
01 1SPIRONOLACTONE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-05-09
Pay. Date : 2022-01-31
DMF Number : 36678
Submission : 2022-02-04
Status : Active
Type : II
20
Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SPIRONOLACTONE USP, with a corresponding US DMF Number 36678.
Remarkably, this DMF maintains an Active status since its submission on February 04, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 09, 2022, and payment made on January 31, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
